Ziopharm Oncology (ZIOP) Tops Q4 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Ziopharm Oncology (ZIOP) Tops Q4 EPS by 5c

BMO Capital Reiterates Bullish Take on ZIOPHARM (ZIOP) Following Meetings; Co. Considering Strategic Options as CAR-T Progresses

February 27, 2015 9:40 AM EST

BMO Capital analyst Jim Birchenough reiterated an Outperform rating and $15 price target on ZIOPHARM Oncology (NASDAQ: ZIOP) following our discussion with management last night, to follow up on recent progress, and ongoing efforts to optimize value of its CAR-T collaboration with MD Anderson.

Birchenough noted that ZIOP acknowledged that it was in... More